On Sunday night, the Food and Drug Administration (FDA) issued an emergency use authorization for hydroxychloroquine and chloroquine, drugs often used to treat malaria and recently touted by President Donald Trump as a possible “game-changer” in the fight against the China-originated novel coronavirus, or COVID-19.
The United States Department of Health & Human Services (HHS) announced in a statement on Sunday that the FDA will allow the drugs to be “donated to the Strategic National Stockpile to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible,” a Politico report said.
The statement noted that “Sandoz donated 30 million doses of hydroxychloroquine to the stockpile and Bayer donated 1 million doses of chloroquine.”
Trump made it clear weeks ago that his administration would work to fast-track promising drugs like hydroxychloroquine with the FDA, all in an effort to combat COVID-19.
Democratic New York Governor Andrew Cuomo is on the same page as President Trump when it comes to the popular anti-malaria drugs, permitting trials of hydroxychloroquine, chloroquine, and azithromycin to commence in his state. – READ MORE
Listen to the insightful Thomas Paine Podcast Below --